Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Controlled in vitro delivery of voriconazole and diclofenac to the cornea using contact lenses for the treatment of Acanthamoeba keratitis.

Morgan SR, Pilia N, Hewitt M, Moses RL, Moseley R, Lewis PN, Morrison PWJ, Kelly SL, Parker JE, Whitaker D, Quantock AJ, Heard CM.

Int J Pharm. 2020 Jan 31;579:119102. doi: 10.1016/j.ijpharm.2020.119102. [Epub ahead of print]

PMID:
32007592
2.

Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma.

Stark FC, Agbayani G, Sandhu JK, Akache B, McPherson C, Deschatelets L, Dudani R, Hewitt M, Jia Y, Krishnan L, McCluskie MJ.

Biomedicines. 2019 Nov 23;7(4). pii: E91. doi: 10.3390/biomedicines7040091.

3.

Analysis of the pharmacological properties of JWH-122 isomers and THJ-2201, RCS-4 and AB-CHMINACA in HEK293T cells and hippocampal neurons.

Costain WJ, Rasquinha I, Comas T, Hewitt M, Aylsworth A, Rouleau Y, Marleau V, Soo EC, Tauskela JS.

Eur J Pharmacol. 2018 Mar 15;823:96-104. doi: 10.1016/j.ejphar.2018.01.043. Epub 2018 Feb 4.

PMID:
29408093
4.

An Ai Chi-based aquatic group improves balance and reduces falls in community-dwelling adults: A pilot observational cohort study.

Skinner EH, Dinh T, Hewitt M, Piper R, Thwaites C.

Physiother Theory Pract. 2016 Nov;32(8):581-590. Epub 2016 Oct 6.

PMID:
27710164
5.

Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca(2+) spiking and multi-electrode arrays.

Tauskela JS, Comas T, Hewitt M, Aylsworth A, Zhao X, Martina M, Costain WJ.

Eur J Pharmacol. 2016 Sep 5;786:148-160. doi: 10.1016/j.ejphar.2016.05.038. Epub 2016 Jun 2.

PMID:
27262380
6.

Pharmacological characterization of emerging synthetic cannabinoids in HEK293T cells and hippocampal neurons.

Costain WJ, Tauskela JS, Rasquinha I, Comas T, Hewitt M, Marleau V, Soo EC.

Eur J Pharmacol. 2016 Sep 5;786:234-245. doi: 10.1016/j.ejphar.2016.05.040. Epub 2016 May 31.

PMID:
27260125
7.

Failure and rescue of preconditioning-induced neuroprotection in severe stroke-like insults.

Tauskela JS, Aylsworth A, Hewitt M, Brunette E, Blondeau N.

Neuropharmacology. 2016 Jun;105:533-542. doi: 10.1016/j.neuropharm.2016.02.007. Epub 2016 Feb 8.

PMID:
26867506
8.

A synthetic peptide corresponding to a region of the human pericentriolar material 1 (PCM-1) protein binds β-amyloid (Aβ1-42 ) oligomers.

Chakravarthy B, Ménard M, Brown L, Hewitt M, Atkinson T, Whitfield J.

J Neurochem. 2013 Aug;126(3):415-24. doi: 10.1111/jnc.12208. Epub 2013 Mar 18.

9.

Preconditioning induces tolerance by suppressing glutamate release in neuron culture ischemia models.

Tauskela JS, Aylsworth A, Hewitt M, Brunette E, Mealing GA.

J Neurochem. 2012 Jul;122(2):470-81. doi: 10.1111/j.1471-4159.2012.07791.x. Epub 2012 Jun 1.

10.

Elevated synaptic activity preconditions neurons against an in vitro model of ischemia.

Tauskela JS, Fang H, Hewitt M, Brunette E, Ahuja T, Thivierge JP, Comas T, Mealing GA.

J Biol Chem. 2008 Dec 12;283(50):34667-76. doi: 10.1074/jbc.M805624200. Epub 2008 Oct 9.

11.

Unconventional neuroprotection against Ca2+ -dependent insults by metalloporphyrin catalytic antioxidants.

Tauskela JS, Brunette E, Kiedrowski L, Lortie K, Hewitt M, Morley P.

J Neurochem. 2006 Aug;98(4):1324-42.

12.

Competing approaches to excitotoxic neuroprotection by inert and catalytic antioxidant porphyrins.

Tauskela JS, Brunette E, Hewitt M, Mealing G, Morley P.

Neurosci Lett. 2006 Jul 3;401(3):236-41. Epub 2006 Apr 24.

PMID:
16631306

Supplemental Content

Loading ...
Support Center